Science in Sport (SISS.L, SIS LN)

  • 20.9
  • 172.4
  • 90.0

    Closing Price (p): 12.1

  • RATING 30/09/22

  • PREVIOUS RATING 09/03/22


Company Profile

Science in Sport is an active lifestyle nutrition platform that operates a dual brand strategy across endurance and lifestyle verticals. Its brands include SiS, a leading endurance nutrition portfolio, and PhD, a leading protein brand family that is expanding into further functional adjacencies. It is a niche player with a premium product offering, anchored by strong internal sports science credentials and a unique innovation model. It operates an omni-channel model, with digital channels comprising 56% of sales. It holds strong market positions domestically (the UK comprises 60% of sales) with strong international growth across Europe, Asia and the US (40% of sales). Its medium-term targets are for £100m of sales and double-digit adjusted EBITDA margins. It is separately targeting 70% of sales from the online and international channels. In FY 2021, it reported revenue of £62.7m and an adjusted EBITDA of £2.2m.

Major Shareholders%
Lombard Odier Asset Mgt. (Europe)21.0
J.O. Hambro Capital Mgt. Ltd.8.9
Aviva Investors Global Services.8.5
Otus Capital Management Ltd.8.2
River & Mercantile Asset Mgt. LLP7.0